Enliven Therapeutics Inc (ELVN)

Currency in USD
61.675
+0.665(+1.09%)
Real-time Data·
Advertisement

Enliven Therapeutics (ELVN) Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy

Technical Indicators

Strong Buy

Moving Averages

Strong Buy

Summary:Strong Buy

Moving Averages:Strong BuyBuy: (12)Sell: (0)
Technical Indicators:Strong BuyBuy: (10)Sell: (0)

Technical Indicators

Summary: Strong BuyBuy: 6Neutral: 4Sell: 1
Aug 26, 2026 16:18 GMT
Name
Value
Action
RSI(14)58.654Buy
STOCH(9,6)50.329Neutral
STOCHRSI(14)54.726Neutral
MACD(12,26)0.368Buy
ADX(14)30.283Neutral
Williams %R-34.36Buy
CCI(14)72.9673Buy
ATR(14)0.7348Less Volatility
Highs/Lows(14)0Neutral
Ultimate Oscillator51.522Buy
ROC-0.041Sell
Bull/Bear Power(13)0.928Buy

Moving Averages

Summary: Strong BuyBuy: 12Sell: 0
Aug 26, 2026 16:18 GMT
Name
Simple
Exponential
MA5
60.836
Buy
60.988
Buy
MA10
60.962
Buy
60.926
Buy
MA20
60.802
Buy
60.615
Buy
MA50
59.674
Buy
59.998
Buy
MA100
59.383
Buy
58.946
Buy
MA200
57.004
Buy
56.715
Buy

Pivot Points

Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic59.57459.93260.42960.78761.28461.64262.139
Fibonacci59.93260.25960.4660.78761.11461.31561.642
Camarilla60.6960.76860.84760.78761.00361.08261.16
Woodie's59.64259.96660.49760.82161.35261.67662.207
DeMark's--60.1860.66361.035--

FAQ

Is Enliven Therapeutics (ELVN) a Buy or Sell, from a Technical Analysis Perspective?

Based on moving averages and other technical indicators, today's Enliven Therapeutics buy/sell signal is Strong Buy.

What Do The Current Moving Averages for Enliven Therapeutics (ELVN) Show?

The moving averages for Enliven Therapeutics show a Strong Buy outlook, considering moving averages ranging from MA5 to MA200, with 12 Buy signals and 0 Sell signals.

What Do Today's Technical Indicators for Enliven Therapeutics Show?

The technical indicators for Enliven Therapeutics are in a Strong Buy position based on daily analysis, with 9 signals on buy indicators and 0 sell signals.

What Is Enliven Therapeutics (ELVN)'s 14-Day RSI?

The current Relative Strength Index (RSI) of ELVN over the 14-day period is 58.654, which suggests that the stock is a Buy.

What Is Enliven Therapeutics (ELVN)'s MACD?

ELVN's MACD (Moving Average Convergence/Divergence) is 0.368, which suggests that the stock is a Buy.

What Is Enliven Therapeutics (ELVN)'s 5-Day Moving Average?

ELVN's 5-day moving average is 60.836, suggesting that the stock is a Buy.

What Is Enliven Therapeutics (ELVN)'s 50-Day Moving Average?

ELVN's 50-day moving average is 59.674, suggesting that the stock is a Buy.

What Is Enliven Therapeutics (ELVN)'s 200-Day Moving Average?

ELVN's 200-day moving average is 57.004, suggesting that the stock is a Buy.

What Is the Fibonacci Pivot Point Performance Value for Enliven Therapeutics (ELVN)?

The Fibonacci pivot point performance value for ELVN is 60.787.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.